---
title: "InSilico Medicine to Join Hang Seng Index"
description: "InSilico Medicine to Join Hang Seng Index"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276400907.md"
published_at: "2026-02-20T01:40:55.000Z"
---

# InSilico Medicine to Join Hang Seng Index

### Related Stocks

- [02800.HK - TRACKER FUND](https://longbridge.com/en/quote/02800.HK.md)
- [03696.HK - INSILICO](https://longbridge.com/en/quote/03696.HK.md)
- [03115.HK - ISHARESHSI](https://longbridge.com/en/quote/03115.HK.md)
- [159920.CN - ChinaAMC Hang Seng ETF](https://longbridge.com/en/quote/159920.CN.md)
- [03037.HK - CSOP HSI ETF](https://longbridge.com/en/quote/03037.HK.md)
- [00HSI.HK - Hang Seng Index](https://longbridge.com/en/quote/00HSI.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Insilico Medicine Unveils AI-Designed ISM5059 as Preclinical NLRP3 Inhibitor Candidate | Insilico Medicine Cayman Topco has nominated ISM5059, an AI-designed small molecule inhibitor targeting NLRP3, as a prec | [Link](https://longbridge.com/en/news/274977240.md) |
| InSilico Medicine Doses First Patient in ISM5411 Study | InSilico Medicine Doses First Patient in ISM5411 Study | [Link](https://longbridge.com/en/news/272203151.md) |
| Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien | Insilico Medicine Cayman Topco has nominated ISM5059 as a preclinical candidate. ISM5059 is an AI-driven, peripherally a | [Link](https://longbridge.com/en/news/274977231.md) |
| InSilico Medicine Ends IPO Stabilization, Fully Exercises Over-Allotment Option | InSilico Medicine Cayman TopCo has concluded the stabilization period for its Hong Kong IPO, with Morgan Stanley Asia Li | [Link](https://longbridge.com/en/news/273383010.md) |
| 08:00 ETInsilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology | Insilico Medicine has appointed Halle Zhang, PhD, as Vice President of Clinical Development – Oncology. Dr. Zhang will l | [Link](https://longbridge.com/en/news/275129503.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.